Skip to main content
Public Health Reports logoLink to Public Health Reports
. 1993 Jan-Feb;108(1):4–11.

States' responses to Title II of the Ryan White CARE Act.

M M McKinney 1, M K Wieland 1, G S Bowen 1, E P Goosby 1, K M Marconi 1
PMCID: PMC1403324  PMID: 8434096

Abstract

Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act of 1990 provides formula-based grants to States to help them improve the quality, availability, and organization of health care and support services for people with human immunodeficiency virus (HIV) infection. This article reviews State expenditures during the first year of CARE Act funding (April 1991-March 1992) within the context of Title II guidelines and the federally funded grant programs that preceded and helped shape Title II. The authors also discuss future challenges that require development of resources, the assessment of program impact, and the evaluation of the quality and appropriateness of HIV-related services. Ninety-one percent of the $77.5 million awarded to States during fiscal year 1991 went for the provision of medical and support services through HIV care consortia, drug reimbursement programs, home and community-based care programs, and health insurance initiatives. The remaining monies were used for planning, evaluation, and program administration. Forty States allocated $38.9 million for the establishment of HIV care consortia to assess service needs and to develop comprehensive continuums of health and support services in the areas most affected by HIV disease. Fifty States allocated an additional $28.3 million for the continuation or expansion of FDA-approved drug therapies for low-income people with HIV infection. Twenty-five States allocated $2.2 million for the provision of home- and community-based health services, and 16 States allocated $1.3 million for programs that help low-income people with HIV infection to purchase or maintain health insurance coverage.

Full text

PDF
6

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baily M. A., Bilheimer L., Wooldridge J., Langwell K., Greenberg W. Economic consequences for Medicaid of human immunodeficiency virus infection. Health Care Financ Rev. 1990 Dec;Spec No:97–108. [PMC free article] [PubMed] [Google Scholar]
  2. Hellinger F. J. Forecasts of the costs of medical care for persons with HIV: 1992-1995. Inquiry. 1992 Fall;29(3):356–365. [PubMed] [Google Scholar]
  3. Wilensky G. R. From the Health Care Financing Administration. JAMA. 1991 Dec 25;266(24):3404–3404. [PubMed] [Google Scholar]

Articles from Public Health Reports are provided here courtesy of SAGE Publications

RESOURCES